global market for mRNA vaccines and therapeutics for non-COVID-19 vaccines is predicted to grow at a CAGR of 95.49% over the forecast period of 2026-2031

NEXT STORY
Pivotal data at ATS 2021 show Dupixent® (dupilumab) significantly reduced asthma attacks and improved lung function in children
PREV STORY
Revive Therapeutics Enters into Feasibility Agreement with LTS Lohmann to Develop Oral Psilocybin Thin Film Strip
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

global market for mRNA vaccines and therapeutics for non-COVID-19 vaccines is predicted to grow at a CAGR of 95.49% over the forecast period of 2026-2031

NEXT STORY
Pivotal data at ATS 2021 show Dupixent® (dupilumab) significantly reduced asthma attacks and improved lung function in children
PREV STORY
Revive Therapeutics Enters into Feasibility Agreement with LTS Lohmann to Develop Oral Psilocybin Thin Film Strip
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Genocea to Present Novel Preclinical Inhibigen™ Data at AACR Annual Meeting 2021

author_avatar
NASDAQ Market News

Targeted Protein Degradation Market, 2020-2030

author_avatar
NASDAQ Market News

Intercept Announces New Data Analysis From FLINT Trial of OCA in NASH Patients with Type 2 Diabetes

Post-hoc analysis showed that patients with both type 2 diabetes and NASH had high ...

author_avatar
NASDAQ Market News